wo2014100481 us modified alpha hemolysin polypeptides
Sep 9, 2026 6:42 AM
# Deep Dive into wo2014100 US20180312551A1 - Modified alpha hemolysin polypeptides and … 481 us modified alpha hemolysin polypeptides
In the field of advanced biophysical research and polymer characterization, protein engineering has opened up remarkable frontiers. My journey into understanding the structure and function of pore-forming toxins led me to the technical complexities detailed in wo2014100481 us modified alpha hemolysin polypeptides. This discussion explores the engineering behind these structures, focusing on how modified amino acid sequences are utilized in high-precision research environments.
The core of the technology described in these patent disclosures revolves around the *Staphylococcus aureus* alpha-hemolysin protein. When researchers refer to a "modified alpha-hemolysin," they are typically discussing a protein scaffold that has been structurally altered at the genetic level to suit specific analytical requirements.
One common aim ob Modified alpha hemolysin polypeptides and methods of use served in the literature is to "reduce the Also provided herein are methods of using modified alpha hemolysin proteins for use in characterizing and/or sequencing a polymer … rate of" translocation. By adjusting the internal channel environment, these modified polypeptides allow for more granular control when analyzing polymers. For instance, specific structural motifs—such as the substitution at H144A or the inclusion of a series of glycine residues spanning residues 127 to 131—are pivotal for researchers looking to stabilize the nanopore within a lipid bilayer or tether a DNA polymerase.
Technical Parameters and Structural Variants
To understand the engineering, one must look at how these polypeptides serve as specialized "nanopores." The term "variant hemolysin" is frequently used to describe these engineered derivatives. My interest in this topic stems from the sheer ingenuity of "long lifetime alpha-hemolysin nanopores," which are designed to withstand the harsh electrical conditions of translocation experiments.
Key observations from the technical data include:
* Engineering Goals: Enhancing the longevity of the pore and fine-tuning the sensing zone.
* Key Mutations: The H144A substitution is a widely cited modification meant to alter the electrostatic interaction or steric properties within the pore mouth.
* Polymer Interaction: The integration of these polypeptides is often intended for "characterizing and/or sequencing a polymer," a task that relies heavily on the consistenc In some embodiments, a modified alpha-hemolysin of the invention is originated or modified from a recombinant or engineered alpha … y of the pore diameter and surface charge.
Practical Perspectives and Research utility
While exploring the technical documentation regarding "alpha-hemolysin variants and uses thereof," it becomes clear that these are not merely proteins; they are precision tools. Whether an *aHL* mutated variant is utilized to improve detection sensitivity or to maintain stability during prolonged sensing, the underlying engineering is a testament to current molecular design capabilities.
For those pursuing the "method of producing an alpha-hemolysin variant," the process typically involves specialized cell culturing techniques and protein purification protocols. Seeing these inventions categorized under various U.S. patents—such as US10906945B2 ( 12 ) United States Patent Craig et al . ( 45 ) Date of Patent : Aug or US10752948B2—highlights how the industry has moved toward standardizing the CORRECTED VERSION - patentimages.storage.googleapis.com se engineered variants for broader academic and analytical applications.
Connecting the Dots: LSI and Entity Context
When evaluating the literature, it is helpful to categorize the information using established entities and terms:
* Entities: *Staphylococcus aureus*, α-hemolysin (a-HL), DNA polymerase.
By synthesizing these details, it is evident that the advancements documented in wo2014100481 and related filings represent a critical phase in the evolution of hardware-biologica Modified alpha-hemolysin: As used herein, the term “modified alpha-hemolysin” refers to an alpha-hemolysin originated from another … l inte US10906945B2 - Modified alpha hemolysin polypeptides and methods … rfaces. The focus on *nanopore* research continues to evolve, with constant refinements in the amino acid sequences ensuring that these biological structures can perform reliably under complex experimental conditions.
Ultimately, the study of these polypeptides involves a rigorous balance of biochemistry and biophysics. By understanding the specific modifications and their roles in modulating the electrical current through the pore, we gain a deeper appreciation for the precision required in modern analytical instrument development.
# Deep Dive into wo2014100 US20180312551A1 - Modified alpha hemolysin polypeptides and … 481 us modified alpha hemolysin polypeptides
In the field of advanced biophysical research and polymer characterization, protein engineering has opened up remarkable frontiers. My journey into understanding the structure and function of pore-forming toxins led me to the technical complexities detailed in wo2014100481 us modified alpha hemolysin polypeptides. This discussion explores the engineering behind these structures, focusing on how modified amino acid sequences are utilized in high-precision research environments.
The core of the technology described in these patent disclosures revolves around the *Staphylococcus aureus* alpha-hemolysin protein. When researchers refer to a "modified alpha-hemolysin," they are typically discussing a protein scaffold that has been structurally altered at the genetic level to suit specific analytical requirements.
One common aim ob Modified alpha hemolysin polypeptides and methods of use served in the literature is to "reduce the Also provided herein are methods of using modified alpha hemolysin proteins for use in characterizing and/or sequencing a polymer … rate of" translocation. By adjusting the internal channel environment, these modified polypeptides allow for more granular control when analyzing polymers. For instance, specific structural motifs—such as the substitution at H144A or the inclusion of a series of glycine residues spanning residues 127 to 131—are pivotal for researchers looking to stabilize the nanopore within a lipid bilayer or tether a DNA polymerase.
Technical Parameters and Structural Variants
To understand the engineering, one must look at how these polypeptides serve as specialized "nanopores." The term "variant hemolysin" is frequently used to describe these engineered derivatives. My interest in this topic stems from the sheer ingenuity of "long lifetime alpha-hemolysin nanopores," which are designed to withstand the harsh electrical conditions of translocation experiments.
Key observations from the technical data include:
* Engineering Goals: Enhancing the longevity of the pore and fine-tuning the sensing zone.
* Key Mutations: The H144A substitution is a widely cited modification meant to alter the electrostatic interaction or steric properties within the pore mouth.
* Polymer Interaction: The integration of these polypeptides is often intended for "characterizing and/or sequencing a polymer," a task that relies heavily on the consistenc In some embodiments, a modified alpha-hemolysin of the invention is originated or modified from a recombinant or engineered alpha … y of the pore diameter and surface charge.
Practical Perspectives and Research utility
While exploring the technical documentation regarding "alpha-hemolysin variants and uses thereof," it becomes clear that these are not merely proteins; they are precision tools. Whether an *aHL* mutated variant is utilized to improve detection sensitivity or to maintain stability during prolonged sensing, the underlying engineering is a testament to current molecular design capabilities.
For those pursuing the "method of producing an alpha-hemolysin variant," the process typically involves specialized cell culturing techniques and protein purification protocols. Seeing these inventions categorized under various U.S. patents—such as US10906945B2 ( 12 ) United States Patent Craig et al . ( 45 ) Date of Patent : Aug or US10752948B2—highlights how the industry has moved toward standardizing the CORRECTED VERSION - patentimages.storage.googleapis.com se engineered variants for broader academic and analytical applications.
Connecting the Dots: LSI and Entity Context
When evaluating the literature, it is helpful to categorize the information using established entities and terms:
* Entities: *Staphylococcus aureus*, α-hemolysin (a-HL), DNA polymerase.
* LSI Terms: Recombinant proteins, lipid bilayer, protein engineering, translocation, molecular sensing.
* Variations: Modified alpha-hemolysin proteins, variant hemolysin gene, engineered pores.
By synthesizing these details, it is evident that the advancements documented in wo2014100481 and related filings represent a critical phase in the evolution of hardware-biologica Modified alpha-hemolysin: As used herein, the term “modified alpha-hemolysin” refers to an alpha-hemolysin originated from another … l inte US10906945B2 - Modified alpha hemolysin polypeptides and methods … rfaces. The focus on *nanopore* research continues to evolve, with constant refinements in the amino acid sequences ensuring that these biological structures can perform reliably under complex experimental conditions.
Ultimately, the study of these polypeptides involves a rigorous balance of biochemistry and biophysics. By understanding the specific modifications and their roles in modulating the electrical current through the pore, we gain a deeper appreciation for the precision required in modern analytical instrument development.